Back to search

Article

Long-lasting Analgesia via Targeted <i>in vivo</i> Epigenetic Repression of Nav1.7

2019-07-24

Abstract excerpt

<h4>ABSTRACT</h4> Current treatments for chronic pain rely largely on opioids despite their unwanted side effects and risk of addiction. Genetic studies have identified in humans key targets pivotal to nociceptive processing, with the voltage-gated sodium channel, Na V 1.7 (SCN9A), being perhaps the most promising candidate for analgesic drug development. Specifically, a hereditary loss-of-function mutation in N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
121f1aec-e0c6-58cd-8af0-013b6d25b053
DOI
10.1101/711812
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-lasting Analgesia via Targeted <i>in vivo</i> Epigenetic Repression of Nav1.7DOI 10.1101/711812
Select a neighboring publication to make it the new centre.